Standard antifungal therapy for pulmonary cryptococcosis to improve prognosis.

Zhang, Boyou; Wang, Lijia; Qian, Banglun; Liu, Wenliang; Shi, Hongcan

Zhang, Boyou; Wang, Lijia; Qian, Banglun; Liu, Wenliang; Shi, Hongcan.

Afiliación

Zhang B; Department of Thoracic Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China; Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu 225001, China; Translational Medicine Research Centre, Yangzhou University, Yangzhou, Jiangsu 225009, China.
Wang L; College of Chemistry and Chemical Engineering, Hunan University, Changsha, Hunan 410082, China.
Qian B; Department of Thoracic Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
Liu W; Department of Thoracic Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China. Electronic address: liuwenliang@csu.edu.cn.
Shi H; Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu 225001, China; Translational Medicine Research Centre, Yangzhou University, Yangzhou, Jiangsu 225009, China. Electronic address: shihongcan@yzu.edu.cn.

Lancet Infect Dis ; 19(12): 1281, 2019 12.

Article en En | MEDLINE | ID: mdl-31782387

Asunto(s)

Criptococosis; Neoplasias Pulmonares; Antifúngicos; Humanos; Pronóstico

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Criptococosis / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2019 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google